false 0001644903 0001644903 2022-10-03 2022-10-03 0001644903 ycbd:CommonCustomMember 2022-10-03 2022-10-03 0001644903 ycbd:SeriesACumulativeConvertiblePreferredStock8CustomMember 2022-10-03 2022-10-03
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) October 3, 2022
 
logo01.jpg
cbdMD, INC.
(Exact name of registrant as specified in its charter)
 
North Carolina
001-38299
47-3414576
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
 
8845 Red Oak Blvd, Charlotte, NC 28217
(Address of principal executive offices) (Zip Code)
 
Registrant's telephone number, including area code: (704) 445-3060
 
_______________________________________
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
common
YCBD
NYSE American
8% Series A Cumulative Convertible Preferred Stock
YCBD PR A
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☑
 
 
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 7.01
Regulation FD Disclosure.
 
Beginning on October 3, 2022, executives of cbdMD, Inc. will begin using the investor deck furnished as Exhibit 99.1 of this Current Report (the “Investor Presentation”) in non-deal road shows. The Investor Presentation will also available under the "Investor" tab in the "Investor Presentations" section of our website located at www.cbdmd.com.
 
Pursuant to General Instruction B.2 of Form 8-K, the information in this Item 7.01 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of cbdMD, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
       
Incorporated by Reference
 
Filed or
No.
 
Exhibit Description
 
Form
 
Date
Filed
 
Number
 
Furnished
Herewith
                     
99.1
               
Furnished
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)                
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
cbdMD, Inc.
     
Date: October 3, 2022
By:
/s/ T. Ronan Kennedy
   
T. Ronan Kennedy, Chief Financial Officer
 
 

Exhibit 99.1

 

 

 

b01.jpg

 

 

 

 
b02.jpg

 

 

 
b03.jpg

 

 

 
b04.jpg

 

 

 
b05.jpg

 

 

 
b06.jpg

 

 

 
b07.jpg

 

 

 
b08.jpg

 

 

 
b09.jpg

 

 

 
b10.jpg

 

 

 
b11.jpg

 

 

 
b12.jpg

 

 

 
b13.jpg

 

 

 
b14.jpg

 

 

 
b15.jpg

 

 

 
b16.jpg

 

 

 
b17.jpg

 

 

 
b18.jpg

 

 

 
b19.jpg

 

 

 
b20.jpg

 

 

 
b21.jpg